Атеротромбоз (Jul 2016)

EFFICACY AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN THE PREVENTION OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION IN EVERYDAY CLINICAL PRACTICE: FACTS ABOUT RIVAROXABAN

  • I. S. Yavelov

DOI
https://doi.org/10.21518/2307-1109-2016-1-69-80
Journal volume & issue
Vol. 0, no. 1
pp. 69 – 80

Abstract

Read online

The article tells about the experience with rivaroxaban for the prevention of stroke and thromboembolism not involving the central nervous system vessels in patients with non-valvular atrial fibrillation in a number of clinical cases. The article demonstrates that rivaroxaban’s efficacy and safety in everyday medical practice, in general, meets the expectations resulting from the large controlled ROCKET-AF trial.

Keywords